Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
  • Disclosures
    • Semiconductors
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form

[Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-01-20

Posted on January 20, 2025August 2, 2026 By K-STOCK Editor No Comments on [Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-01-20

Fact Source: Financial Supervisory Service DART

💡 Executive Summary

Hana Micron will hold an IR session for domestic and foreign institutional investors and analysts to present and answer questions regarding its spin-off and transition to a holding company.

📊 Key Disclosure Content & Financial Figures Summary

  1. Company Name: Hana Micron Inc.
  2. Date & Time: January 22, 2025 (11:30 ~ 13:00 local time)
  3. Location: CCMM, Yeouido
  4. Target Audience: Domestic and foreign institutional investors and analysts
  5. Purpose: IR session regarding spin-off and transition to a holding company
  6. Format:
    • Presentation and Q&A regarding spin-off and transition to a holding company (Multi-party face-to-face meeting)
    • IR video posting on company website ‘IR Library’ after event
  7. Main Content: Explanation regarding spin-off and transition to a holding company
  8. Sponsor: Not specified
  9. IR Material Posting:
    • Date & Time: January 22, 2025 at 11:00
    • Location: Company website (https://www.hanamicron.com) and Korea Exchange KIND System (https://kind.krx.co.kr) ‘IR Library’

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Reviewing Published IR Materials and Official Filings

This filing announces an Investor Relations event organized to explain the details of the proposed spin-off and holding company transition to institutional investors and analysts. Reviewing the presentation materials and video recording posted on the company’s website or KIND is important for examining the details provided regarding corporate restructuring. Official information and related details can be verified through the company’s IR repository, KIND, and official disclosures.

📢 Disclaimer & Source Information

Source: This content was structured and regenerated based on official data submitted to the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Disclaimer: This content is provided solely for information purposes and linguistic reference. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific securities. All investment decisions and financial risks rest solely with the investor.

Contact: For compliance inquiries or copyright-related issues, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Semiconductors

Post navigation

Previous Post: [Disclosure] ALTEOGEN (196170) – Clarification on Rumors or News Reports (Unconfirmed) / 2025-01-20
Next Post: [Disclosure] Daeduck Electronics (353200) – Investor Relations (IR) Holding (Information Disclosure) / 2025-01-21

Related Posts

[Disclosure] ISU PETASYS (007660) – Submission of Audit Report / 2025-03-20 Semiconductors
[Disclosure] Hanwha Ocean (042660) – Resolution on Board Meeting for General Meeting of Shareholders / 2025-02-18 Disclosures
[Disclosure] Samsung Electro-Mechanics (009150) – Change in Sales or Profit/Loss Structure Exceeding 30% (15% for Large Scale Corporation) / 2025-01-24 Semiconductors
[Disclosure] ALTEOGEN (196170) – Termination of License Agreement and Return of Rights (ALT-B4 Technology) / 2024-07-30 Disclosures
[Disclosure] Celltrion (068270) – Provisional Consolidated Financial Results (Fair Disclosure) / 2025-07-21 Disclosures
[Disclosure] Hana Micron (067310) – Decision on Cash/In-Kind Dividend / 2024-03-13 Disclosures

Leave a Reply Cancel reply

You must be logged in to post a comment.

  • [Disclosure] Hanwha Ocean (042660) – Clarification on Rumors or Reports (Unconfirmed) / 2026-08-07August 7, 2026
  • [Disclosure] ALTEOGEN (196170) – Exclusive License Agreement for Recombinant Human Hyaluronidase Product ALT-B4 / 2026-08-05August 5, 2026
  • [Disclosure] ALTEOGEN (196170) – Ex-Rights (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] ALTEOGEN (196170) – Market Measures on Stock Futures and Options (Bonus Issue) / 2026-08-04August 4, 2026
  • [Disclosure] Celltrion (068270) – CT-P44 (Darzalex Biosimilar) Korea Phase 3 Clinical Trial Plan Amendment Application / 2026-08-03August 3, 2026

Copyright © 2026 K-Stock Briefing.

Powered by PressBook Grid Dark theme